EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting

Antonella Rocchi iD, Valeria Sidorenko, Nicola d'Avanzo, Luca Marchetti, Jhalak Sethi, Luigi Ciriolo, Anna Maria Tolomeo, Maria Grazia Cifone, Paola Palumbo, Massimo Fresta iD, Tambet Teesalu, Christian Celia iD

ACS Pharmacology & Translational Science · 2025-10-10 · 8 (10) · 3654-3668

DOI: 10.1021/acsptsci.5c00537 ↗

At a glance

Journal article in ACS Pharmacology & Translational Science, published online on 2025-09-30. Written by Antonella Rocchi and 11 co-authors. Institution: Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, Tartu 50411, Estonia. Cited 2 times so far (Crossref); 92 references. The full text is freely available (open access, CC BY 4.0). Funded by: Transcan, Consiglio Nazionale delle Ricerche, Estonian Research Competency Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Glioblastoma multiforme (GBM) is an aggressive brain tumor with limited therapeutic options and a poor prognosis. We developed hybrid lipid-polymer nanoparticles (HLPNs) functionalized with tumor-homing C-end Rule peptide LinTT1 (LinTT1-HLPNs) to improve the GBM targeting. In vitro studies demonstrated that LinTT1-HLPNs bind selectively to GBM cells and significantly improved the cytotoxicity of the loaded temozolomide (TMZ) (LinTT1-HLPNs@TMZ) compared to that of the free drug. In vivo, intravenous injection of HLPNs in both infiltrative and noninfiltrative GBM murine models had an enhanced accumulation of TMZ in the tumor area, thus endorsing the selective targeting and tissue penetration of LinTT1-HLPNs. This nanoplatform combines the advantages of hybrid lipid-polymer nanoparticles with a GBM-specific targeting strategy, thus providing an improved drug delivery and therapeutic effect by a multistep targeting approach, which addresses the key challenge of GBM.

Subjects

Author keywords

CendR peptideglioblastoma multiformehybrid nanoparticlesnanomedicineprecision medicinetumor homing peptides

Authors and institutions

  • Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, Tartu 50411, Estonia.
  • Department of Pharmacy, University of Chieti - Pescara "G. d'Annunzio", Via dei Vestini 31, Chieti 66100, Italy.
  • Division of GI/Endocrine Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Department of Clinical and Experimental Medicine, University of Catanzaro "Magna Græcia", V.le "S. Venuta", Catanzaro I-88100, Italy.
  • Research Center "ProHealth Translational Hub", Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Campus Universitario "S. Venuta" - Building of BioSciences, Viale S. Venuta, Cata…
  • Department of Health Science, University of Catanzaro "Magna Græcia", V.le "S. Venuta", Catanzaro I-88100, Italy.

ORCID profiles: Antonella Rocchi, Massimo Fresta, Christian Celia

Funding

  • Transcan
  • Consiglio Nazionale delle Ricerche
  • Estonian Research Competency Council
  • Ministero dell'Universit? e della Ricerca
  • EuroNanoMed III
  • NextGenerationEU

Cite

APA

Rocchi, A., Sidorenko, V., d'Avanzo, N., Marchetti, L., Sethi, J., Ciriolo, L., Tolomeo, A. M., Cifone, M. G., Palumbo, P., Fresta, M., Teesalu, T., & Celia, C. (2025). LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting. ACS Pharmacology & Translational Science, 8(10), 3654-3668. https://doi.org/10.1021/acsptsci.5c00537

Vancouver

Rocchi A, Sidorenko V, d'Avanzo N, Marchetti L, Sethi J, Ciriolo L, et al. LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting. ACS Pharmacology & Translational Science. 2025;8(10):3654-3668. doi:10.1021/acsptsci.5c00537

BibTeX
@article{Rocchi2025,
  author = {Rocchi, Antonella and Sidorenko, Valeria and d'Avanzo, Nicola and Marchetti, Luca and Sethi, Jhalak and Ciriolo, Luigi and Tolomeo, Anna Maria and Cifone, Maria Grazia and Palumbo, Paola and Fresta, Massimo and Teesalu, Tambet and Celia, Christian},
  title = {LinTT1-Functionalized Hybrid Lipid–Polymer Nanoparticles for Glioblastoma Targeting},
  journal = {ACS Pharmacology & Translational Science},
  year = {2025},
  volume = {8},
  number = {10},
  pages = {3654--3668},
  doi = {10.1021/acsptsci.5c00537}
}
Start for free →